Fractyl is presenting the latest results from its trial of a gene therapy called Rejuva in mice at the annual meeting of the Obesity Society, called ObesityWeek, which is being held in Atlanta this week
Ultimately, the decision to continue or discontinue GLP-1 treatment after reaching your weight loss goal should be based on a comprehensive assessment of your individual health needs, potential benefits, and any risks associated with long-term use of the medication
Cost considerations Because retatrutide is not commercially approved or available through ordinary pharmacy channels, there is no legitimate standard online price, retail cash price, insurance price, or manufacturer savings-card pathway for retatrutide at this time
If the provider determines that GLP-1 medications are not appropriate for you based on your medical history, contraindications, or other health factors, you will not receive a prescription
JAMA, 332 (7), 571-584
Weekly subcutaneous dosing remains adequate despite the moderately shorter duration compared to Semaglutide
